Tetracaine
Tetracaine is a pharmaceutical drug with 7 clinical trials. Historical success rate of 85.7%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
0
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
85.7%
6 of 7 finished
14.3%
1 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Dorsal Penile Nerve Block for Rigid Cystoscopy in Men
Study to Determine the Effect of a Newly Formulated Tetracaine Product PET500 on Penile Skin Sensation
Decision Support for Intraoperative Low Blood Pressure
Tetracaine Combined Spinal Epidural (CSE) Versus Bupivacaine CSE
Ametop - Friend and Foe A Prospective Study of the Incidence of Adverse Reactions With Ametop
Clinical Trials (7)
Dorsal Penile Nerve Block for Rigid Cystoscopy in Men
Study to Determine the Effect of a Newly Formulated Tetracaine Product PET500 on Penile Skin Sensation
Decision Support for Intraoperative Low Blood Pressure
Tetracaine Combined Spinal Epidural (CSE) Versus Bupivacaine CSE
Ametop - Friend and Foe A Prospective Study of the Incidence of Adverse Reactions With Ametop
Efficacy and Safety Assessment of Intracameral Injection of T2380 in Cataract Surgery
Intravitreal Injection Anesthesia - Comparison of Different Topical Agents
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7